Global Artificial Tears Market: By Type (Polyethylene Glycol and Propylene Glycol-Based Tears, Cellulose-based Tears, and Others), By Distribution (Hospitals, Offline Retail Pharmacies, and Online Retail Pharmacies), and Region ? Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030.

Report ID : AMR1004248 | Industries : Others | Published On :December 2023 | Page Count : 210

Request Sample
Ask for Customization

Global Artificial Tears Market: By Type (Polyethylene Glycol and Propylene Glycol-Based Tears, Cellulose-based Tears, and Others), By Distribution (Hospitals, Offline Retail Pharmacies, and Online Retail Pharmacies), and Region – Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030.


Global Artificial Tears Market


The Global Artificial Tears Market was valued at USD 3.11 billion in 2022 and is expected to reach USD 6.43 billion by 2030 at a CAGR of 6.31% from 2023-2030.
Artificial tears are eye lubricating products that are primarily aimed at relieving symptoms of dry eyes and other eye-related issues. Artificial tears are an important part of eye treatments, and they can be prescribed or be used as over-the-counter medication. Artificial tears are also used for moistening contact lenses which tend to become dry with time.


Market Drivers


The global market for artificial tears is primarily driven by the growing occurrences of eye problems. As people age, the risk of developing dry eyes and related ocular discomfort rises, leading to a growing market for such products. Moreover, the growing and widespread use of digital devices and prolonged screen time have become common features of modern lifestyles, causing digital eye strain and dryness, which further boosts the demand for artificial tears.
Additionally, environmental factors, such as pollution and climate conditions, can aggravate dry eye symptoms. The increasing awareness about eye health is encouraging more individuals to seek over-the-counter artificial tears for immediate relief.


Market Restraints


One major restraint to the growth of the global artificial tears market is the possibility of developing allergic reactions to the product. The general resistance and unwillingness to use artificial tears, especially for long term use, also affects the long-term growth of the market. There is a rise in alternative therapies and natural and preservative-free products that are diverting the focus from using artificial tears products.
Moreover, artificial tears formulations are at the risk of being counterfeited, which can affect consumer confidence, ultimately impacting the market’s growth. The cost of long-term usage of artificial tears may not be feasible to lower and middle-level income groups, limiting the adoption of the product to only higher-income groups.


Market Segmentation


The scope of the global Artificial Tears market covers segmentation based on type, distribution, and region.
Based on the type, the market is segmented into polyethylene glycol and propylene glycol-Based tears, cellulose-based tears, and others. Based on the distribution, the market is segmented into hospitals, offline retail pharmacies, and online retail pharmacies.


Regional Analysis


The Global Artificial Tears Market is segmented into 5 main regions, namely, North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The Asia-Pacific region is anticipated to witness significant market expansion. This growth is driven by the rising middle-class population and their increasing disposable incomes which allows these income groups to afford products of artificial tears. Additionally, the growing awareness of eye health, and the apparent changes in lifestyle, such as the prolonged screen time and exposure to environmental factors is leading to the increased use of artificial tears, leading to rapid market growth.


Key Players


Johnson & Johnson, Alcon, Santen Pharmaceutical, Akorn, Novartis, Bausch & Lomb, AbbVie Inc., Bayer AG, Aurolab, Prestige Consumer Healthcare.


Market Taxonomy


By Type
• Polyethylene Glycol and Propylene Glycol-Based Tears
• Cellulose-based Tears
• Others
By Distribution
• Hospitals
• Offline Retail Pharmacies
• Online Retail Pharmacies
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o UK
o France
o Netherlands
o Italy
o Belgium
o Rest of Europe
• Asia Pacific
o China
o India
o South Korea
o Japan
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Tanzania
o Rest Middle East & Africa
 

 

Inquire Before Buying Request Free Sample Ask For Discount

Global Artificial Tears Market


1. Introduction
1.1. Objective of the Study
1.2. Market Definition
1.3. Market Scope
2. Research Methodology
2.1. Data Mining
2.2. Validation
2.3. Primary Interviews
2.4. List of Data Sources
3. Executive Summary
4. Global Artificial Tears Market Outlook
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Cumulative Impact due to recent Energy Crisis
4.2.5. Cumulative Impact due to Nearing Economic Downturn
4.2.6. Post Covid-19 World Supply and Demand Conditions
4.2.7. Cumulative Impact of Russia-Ukraine Conflict
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. Global Artificial Tears Market, By Type
5.1. Y-o-Y Growth Comparison, By Type
5.2. Global Artificial Tears Market Share Analysis, By Type
5.3. Global Artificial Tears Market Size and Forecast, By Type
5.3.1. Polyethylene Glycol and Propylene Glycol-Based Tears
5.3.2. Cellulose-based Tears
5.3.3. Others
6. Global Artificial Tears Market, By Distribution
6.1. Y-o-Y Growth Comparison, By Distribution
6.2. Global Artificial Tears Market Share Analysis, By Distribution
6.3. Global Artificial Tears Market Size and Forecast, By Distribution
6.3.1. Hospitals
6.3.2. Offline Retail Pharmacies
6.3.3. Online Retail Pharmacies
7. Global Artificial Tears Market, By Region
7.1. Global Artificial Tears Market Share Analysis, By Region
7.2. Global Artificial Tears Market Share Analysis, By Region
7.3. Global Artificial Tears Market Size and Forecast, By Region
8. North America Artificial Tears Market Analysis and Forecast (2023-2030)
8.1. Introduction
8.2. North America Artificial Tears Market Share Analysis, By Type
8.3. North America Artificial Tears Market Share Analysis, By Distribution
8.4. North America Artificial Tears Market Size and Forecast, By Country
8.4.1. U.S.
8.4.1.1. Market Size and Forecast, By Type
8.4.1.2. Market Size and Forecast, By Distribution
8.4.2. Canada
8.4.2.1. Market Size and Forecast, By Type
8.4.2.2. Market Size and Forecast, By Distribution
8.4.3. Mexico
8.4.3.1. Market Size and Forecast, By Type
8.4.3.2. Market Size and Forecast, By Distribution
9. Europe Artificial Tears Market Analysis and Forecast (2023-2030)
9.1. Introduction
9.2. Europe Artificial Tears Market Share Analysis, By Type
9.3. Europe Artificial Tears Market Share Analysis, By Distribution
9.4. Europe Artificial Tears Market Size and Forecast, By Country
9.4.1. Germany
9.4.1.1. Market Size and Forecast, By Type
9.4.1.2. Market Size and Forecast, By Distribution
9.4.2. France
9.4.2.1. Market Size and Forecast, By Type
9.4.2.2. Market Size and Forecast, By Distribution
9.4.3. UK
9.4.3.1. Market Size and Forecast, By Type
9.4.3.2. Market Size and Forecast, By Distribution
9.4.4. Russia
9.4.4.1. Market Size and Forecast, By Type
9.4.4.2. Market Size and Forecast, By Distribution
9.4.5. Italy
9.4.5.1. Market Size and Forecast, By Type
9.4.5.2. Market Size and Forecast, By Distribution
9.4.6. Spain
9.4.6.1. Market Size and Forecast, By Type
9.4.6.2. Market Size and Forecast, By Distribution
9.4.7. Rest of Europe
9.4.7.1. Market Size and Forecast, By Type
9.4.7.2. Market Size and Forecast, By Distribution
10. Asia Pacific Artificial Tears Market Analysis and Forecast (2023-2030)
10.1. Introduction
10.2. Asia Pacific Artificial Tears Market Share Analysis, By Type
10.3. Asia Pacific Artificial Tears Market Share Analysis, By Distribution
10.4. Asia Pacific Artificial Tears Market Size and Forecast, By Country
10.4.1. China
10.4.1.1. Market Size and Forecast, By Type
10.4.1.2. Market Size and Forecast, By Distribution
10.4.2. Japan
10.4.2.1. Market Size and Forecast, By Type
10.4.2.2. Market Size and Forecast, By Distribution
10.4.3. India
10.4.3.1. Market Size and Forecast, By Type
10.4.3.2. Market Size and Forecast, By Distribution
10.4.4. South Korea
10.4.4.1. Market Size and Forecast, By Type
10.4.4.2. Market Size and Forecast, By Distribution
10.4.5. Australia
10.4.5.1. Market Size and Forecast, By Type
10.4.5.2. Market Size and Forecast, By Distribution
10.4.6. New Zealand
10.4.6.1. Market Size and Forecast, By Type
10.4.6.2. Market Size and Forecast, By Distribution
10.4.7. Singapore
10.4.7.1. Market Size and Forecast, By Type
10.4.7.2. Market Size and Forecast, By Distribution
10.4.8. Malaysia
10.4.8.1. Market Size and Forecast, By Type
10.4.8.2. Market Size and Forecast, By Distribution
10.4.9. Rest of Asia
10.4.9.1. Market Size and Forecast, By Type
10.4.9.2. Market Size and Forecast, By Distribution
11. Latin America Artificial Tears Market Analysis and Forecast (2023-2030)
11.1. Introduction
11.2. Latin America Artificial Tears Market Share Analysis, By Type
11.3. Latin America Artificial Tears Market Share Analysis, By Distribution
11.4. Latin America Artificial Tears Market Size and Forecast, Country
11.4.1. Brazil
11.4.1.1. Market Size and Forecast, By Type
11.4.1.2. Market Size and Forecast, By Distribution
11.4.2. Argentina
11.4.2.1. Market Size and Forecast, By Type
11.4.2.2. Market Size and Forecast, By Distribution
11.4.3. Colombia
11.4.3.1. Market Size and Forecast, By Type
11.4.3.2. Market Size and Forecast, By Distribution
11.4.4. Peru
11.4.4.1. Market Size and Forecast, By Type
11.4.4.2. Market Size and Forecast, By Distribution
11.4.5. Chile
11.4.5.1. Market Size and Forecast, By Type
11.4.5.2. Market Size and Forecast, By Distribution
11.4.6. Venezuela
11.4.6.1. Market Size and Forecast, By Type
11.4.6.2. Market Size and Forecast, By Distribution
11.4.7. Rest of Latin America
11.4.7.1. Market Size and Forecast, By Type
11.4.7.2. Market Size and Forecast, By Distribution
12. Middle East Artificial Tears Market Analysis and Forecast (2023-2030)
12.1. Introduction
12.2. Middle East Artificial Tears Market Share Analysis, By Type
12.3. Middle East Artificial Tears Market Size and Forecast, By Distribution
12.4. Middle East Artificial Tears Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.1.1. Market Size and Forecast, By Type
12.4.1.2. Market Size and Forecast, By Distribution
12.4.2. UAE
12.4.2.1. Market Size and Forecast, By Type
12.4.2.2. Market Size and Forecast, By Distribution
12.4.3. Egypt
12.4.3.1. Market Size and Forecast, By Type
12.4.3.2. Market Size and Forecast, By Distribution
12.4.4. Kuwait
12.4.4.1. Market Size and Forecast, By Type
12.4.4.2. Market Size and Forecast, By Distribution
12.4.5. South Africa
12.4.5.1. Market Size and Forecast, By Type
12.4.5.2. Market Size and Forecast, By Distribution
12.4.6. Rest of Middle East & Africa
12.4.6.1. Market Size and Forecast, By Type
12.4.6.2. Market Size and Forecast, By Distribution
13. Competitive Analysis
13.1. Competition Dashboard
13.2. Market share Analysis of Top Vendors
13.3. Key Development Strategies
14. Company Profiles
14.1. Johnson & Johnson
14.1.1. Overview
14.1.2. Offerings
14.1.3. Key Financials
14.1.4. Business Segment & Geographic Overview
14.1.5. Key Market Developments
14.1.6. Key Strategies
14.2. Alcon
14.2.1. Overview
14.2.2. Offerings
14.2.3. Key Financials
14.2.4. Business Segment & Geographic Overview
14.2.5. Key Market Developments
14.2.6. Key Strategies
14.3. Santen Pharmaceutical
14.3.1. Overview
14.3.2. Offerings
14.3.3. Key Financials
14.3.4. Business Segment & Geographic Overview
14.3.5. Key Market Developments
14.3.6. Key Strategies
14.4. Akorn
14.4.1. Overview
14.4.2. Offerings
14.4.3. Key Financials
14.4.4. Business Segment & Geographic Overview
14.4.5. Key Market Developments
14.4.6. Key Strategies
14.5. Novartis
14.5.1. Overview
14.5.2. Offerings
14.5.3. Key Financials
14.5.4. Business Segment & Geographic Overview
14.5.5. Key Market Developments
14.5.6. Key Strategies
14.6. Bausch & Lomb
14.6.1. Overview
14.6.2. Offerings
14.6.3. Key Financials
14.6.4. Business Segment & Geographic Overview
14.6.5. Key Market Developments
14.6.6. Key Strategies
14.7. AbbVie Inc.
14.7.1. Overview
14.7.2. Offerings
14.7.3. Key Financials
14.7.4. Business Segment & Geographic Overview
14.7.5. Key Market Developments
14.7.6. Key Strategies
14.8. Bayer AG
14.8.1. Overview
14.8.2. Offerings
14.8.3. Key Financials
14.8.4. Business Segment & Geographic Overview
14.8.5. Key Market Developments
14.8.6. Key Strategies
14.9. Aurolab
14.9.1. Overview
14.9.2. Offerings
14.9.3. Key Financials
14.9.4. Business Segment & Geographic Overview
14.9.5. Key Market Developments
14.9.6. Key Strategies
14.10. Prestige Consumer Healthcare
14.10.1. Overview
14.10.2. Offerings
14.10.3. Key Financials
14.10.4. Business Segment & Geographic Overview
14.10.5. Key Market Developments
14.10.6. Key Strategies

 

 

Inquire Before Buying Request Free Sample Ask For Discount